Frankly, we needed this. As we close the book on six whole months of this "new normal," our Quality Matters news brief rounds up causes for optimism for the next six months.
Though we may not have a magic bullet, we've gotten better at treating severe cases of COVID-19; some unique inter-disciplinary competencies are improving care at an unprecedented speed; and a range of vaccines and potential treatments are entering phase three trials.
Plus, we look at the impetus to improve coordination of clinical science, in general, and ask the question—can accreditation help us build the infrastructure to improve science and outcomes more quickly? |